회원공간
공지사항
제5차 골다공증 전문가 양성을 위한 교육 프로그램 안내
작성자
인포랑 관리자
작성일
2008-01-16
조회
8211
첨부파일
(Down : 1028)
2008 Osteoporosis Expert Meeting (preliminary program)

☞ Date: Feb. 16-17 (Sat-Sun), 2008

☞ Venue: Incheon Hyatt Hotel (near the Incheon International Airport)

☞ Official Language: English (1st day) and Korean (2nd day)

 

1st day (Feb. 16th, Saturday)
Official Language: English
Registration 08:30-08:50
Opening remarks 08:50-09:00
I. Risk Factors (Chairmen: Jung Gu Kim and Robert Wen-Wei Hsu) 09:00-10:40
1. Epidemiology and socio-economic burden of osteoporosis and fracture.
Nam H. Cho (Korea)
09:00-09:30
2. Genetics and SNP analysis of osteoporosis.
Dong Ock Lee (Korea)
09:30-09:50
3. Nutrition and prevention of osteoporosis.
Takako Hirota (Japan)
09:50-10:20
4. Discussion. 10:20-10:40
Coffee Break 10:40-11:00
II. Pathophysiology (Chairperson: Ghi Su Kim ) 11:00-12:00
1. Primary osteoporosis. Yoo Mee Kim (Korea) 11:00-11:20
2. Secondary osteoporosis. Chan Soo Shin (Korea) 11:20-11:40
3. Discussion 11:40-12:00
Plenary Lecture: Chairman: Woong Hwan Choi  
Osteoclastogenesis and vitamin D. Tatsuo Suda (Japan) 12:00-12:40
Luncheon 12:40-13:40
III. Bone Biology (Chairmen: Toshiyuki Yoneda , Hyun-Mo Ryoo) 13:40-15:00
1. Regulation of osteoblast differentiation by BMP
and Notch signaling. Akira Yamaguchi (Japan)
13:40-14:10
2. Role of chondrocyte in bone. Ung-il Chung (Japan) 14:10-14:40
3. Discussion 14:40-15:00
Coffee Break 15:00-15:20
IV. Diagnostic Methods
(Chairmen: Seoung-Oh Yang accepted, Deog Yoon Kim )
15:20-18:00
1. The future of DXA – more than just BMD. Kevin Wilson (USA) 15:20-15:50
2. QCT and biomechanics. Keenan (USA) 15:50-16:20
3. Biochemical bone markers. Yoon-Sok Chung (Korea) 16:20-16:40
4. Histomorphometric analysis. Satoshi Mori (Japan) 16:40-17:10
5. Role of chondrocyte in bone. Ung-il Chung (Japan) 17:10-17:40
6. Discussion 17:40-18:00
Dinner 18:00-20:00

 

2nd day (Feb. 17th, Sunday)
Official Language: Korean (English for overseas speakers)

Registration 08:00-08:30

Plenary Lecture: Chairman: Sung-Kil Lim

 
Role of vitamin D in osteoporosis treatment. Hajime Orimo (Japan) 08:30-09:10
V. Treatments, new trends and perspectives 09:10-13:00
A) Estrogen & SERM (Chairman: Hoon Choi ) 09:10-10:00
1. Clinical & low dose estrogen. Hong-Yuan Huang (Taiwan) 09:10-09:30
2. Selective Estrogen Receptor Modulator. Byung Koo Yoon (Korea) 09:30-09:50
3. Discussion 09:50-10:00
B) Bisphosphonates (Chairman: Ye Yeon Won ) 10:00-11:00
1. Daily or weekly bisphosphonates. Takayuki Hosoi (Japan) 10:00-10:25
2. Monthly or yearly bisphosphonates. Dong Won Byun (Korea) 10:25-10:50
3. Discussion 10:50-11:00
Coffee Break 11:00-11:20
C) Anabolic agents (Chairman: Moo Il Kang ) 11:20-12:10
1. Parathyroid hormone. Yumie Rhee 11:20-11:40
2. Strontium ranelate. Ho-Yeon Chung (Korea) 11:40-12:00
3. Discussion 12:00-12:10
D) Surgery for osteoporotic fractures (Chairman: JM Lee ) 12:10-13:00
1. Spine fractures. Hak Sun Kim (Korea) 12:10-12:30
2. Hip fractures. Robert Wen-Wei Hsu (Taiwan) 12:30-12:50
3. Discussion 12:50-13:00
Luncheon 13:00-14:00
Closing remarks 14:00-14:20